Korean drug makers see falling market share in April

The country’s Korean leading pharmaceutical companies including top-tier ones have struggled to find their feet in April due to the adverse effects of a government-mandated price cut, while multinational drug firms are expanding their share and strengthening their grip on the domestic market.

Market leaders like Dong-A Pharmaceutical, Daewoong Pharmaceutical, Yuhan Corporation and Hanmi Phar...